Effects of size and sequence on the iontophoretic delivery of oligonucleotides

Rhonda M. Brand, Andrew O Wahl, Patrick L. Iversen

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Adequate cellular availability of synthetic oligonucleotides is crucial to their success as therapeutic agents. These compounds, however, are not expected to be orally active. This has led to interest in a variety of alternate drug delivery methods, including iontophoretically enhanced transdermal delivery. The purpose of this work is to begin characterizing the structure-activity relationship for iontophoresis of oligonucleotides through the skin. The in vitro permeation of 16 biologically relevant phosphorothioate oligonucleotides across hairless mouse skin was studied. Oligonucleotides with less than 20 bases (n = 10) had a wide range of steady- state flux levels (2.1-26.2 pmol/cm2 h). A lower flux differential was observed for compounds ranging from 20 to 40 bases long (1.2-2.2 pmol/cm2 h). For the smaller compounds, transport, in general, decreased with increasing size; however, there were several oligonucleotides that did not follow this pattern. These data indicate that factors other than size influence transport and that the impact is greater at shorter lengths. Differential penetration between equal sized oligonucleotides synthesized with identical bases in reversed order indicates that sequence and not simply base composition affects steady-state flux across skin. Molecular structure, therefore, is a key contributor to iontophoretically assisted transport. Further studies are necessary to develop more precise predictions about the relationship between oligonucleotide structure and transdermal delivery.

Original languageEnglish (US)
Pages (from-to)49-52
Number of pages4
JournalJournal of Pharmaceutical Sciences
Volume87
Issue number1
DOIs
StatePublished - Jan 1 1998

Fingerprint

Oligonucleotides
Skin
Fluxes
Phosphorothioate Oligonucleotides
Hairless Mouse
Iontophoresis
Base Composition
Structure-Activity Relationship
Molecular Structure
Drug delivery
Permeation
Molecular structure
Availability
Chemical analysis
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Effects of size and sequence on the iontophoretic delivery of oligonucleotides. / Brand, Rhonda M.; Wahl, Andrew O; Iversen, Patrick L.

In: Journal of Pharmaceutical Sciences, Vol. 87, No. 1, 01.01.1998, p. 49-52.

Research output: Contribution to journalArticle

@article{194780549bf642f3ba91749c59c2e4c6,
title = "Effects of size and sequence on the iontophoretic delivery of oligonucleotides",
abstract = "Adequate cellular availability of synthetic oligonucleotides is crucial to their success as therapeutic agents. These compounds, however, are not expected to be orally active. This has led to interest in a variety of alternate drug delivery methods, including iontophoretically enhanced transdermal delivery. The purpose of this work is to begin characterizing the structure-activity relationship for iontophoresis of oligonucleotides through the skin. The in vitro permeation of 16 biologically relevant phosphorothioate oligonucleotides across hairless mouse skin was studied. Oligonucleotides with less than 20 bases (n = 10) had a wide range of steady- state flux levels (2.1-26.2 pmol/cm2 h). A lower flux differential was observed for compounds ranging from 20 to 40 bases long (1.2-2.2 pmol/cm2 h). For the smaller compounds, transport, in general, decreased with increasing size; however, there were several oligonucleotides that did not follow this pattern. These data indicate that factors other than size influence transport and that the impact is greater at shorter lengths. Differential penetration between equal sized oligonucleotides synthesized with identical bases in reversed order indicates that sequence and not simply base composition affects steady-state flux across skin. Molecular structure, therefore, is a key contributor to iontophoretically assisted transport. Further studies are necessary to develop more precise predictions about the relationship between oligonucleotide structure and transdermal delivery.",
author = "Brand, {Rhonda M.} and Wahl, {Andrew O} and Iversen, {Patrick L.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1021/js9701871",
language = "English (US)",
volume = "87",
pages = "49--52",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Effects of size and sequence on the iontophoretic delivery of oligonucleotides

AU - Brand, Rhonda M.

AU - Wahl, Andrew O

AU - Iversen, Patrick L.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Adequate cellular availability of synthetic oligonucleotides is crucial to their success as therapeutic agents. These compounds, however, are not expected to be orally active. This has led to interest in a variety of alternate drug delivery methods, including iontophoretically enhanced transdermal delivery. The purpose of this work is to begin characterizing the structure-activity relationship for iontophoresis of oligonucleotides through the skin. The in vitro permeation of 16 biologically relevant phosphorothioate oligonucleotides across hairless mouse skin was studied. Oligonucleotides with less than 20 bases (n = 10) had a wide range of steady- state flux levels (2.1-26.2 pmol/cm2 h). A lower flux differential was observed for compounds ranging from 20 to 40 bases long (1.2-2.2 pmol/cm2 h). For the smaller compounds, transport, in general, decreased with increasing size; however, there were several oligonucleotides that did not follow this pattern. These data indicate that factors other than size influence transport and that the impact is greater at shorter lengths. Differential penetration between equal sized oligonucleotides synthesized with identical bases in reversed order indicates that sequence and not simply base composition affects steady-state flux across skin. Molecular structure, therefore, is a key contributor to iontophoretically assisted transport. Further studies are necessary to develop more precise predictions about the relationship between oligonucleotide structure and transdermal delivery.

AB - Adequate cellular availability of synthetic oligonucleotides is crucial to their success as therapeutic agents. These compounds, however, are not expected to be orally active. This has led to interest in a variety of alternate drug delivery methods, including iontophoretically enhanced transdermal delivery. The purpose of this work is to begin characterizing the structure-activity relationship for iontophoresis of oligonucleotides through the skin. The in vitro permeation of 16 biologically relevant phosphorothioate oligonucleotides across hairless mouse skin was studied. Oligonucleotides with less than 20 bases (n = 10) had a wide range of steady- state flux levels (2.1-26.2 pmol/cm2 h). A lower flux differential was observed for compounds ranging from 20 to 40 bases long (1.2-2.2 pmol/cm2 h). For the smaller compounds, transport, in general, decreased with increasing size; however, there were several oligonucleotides that did not follow this pattern. These data indicate that factors other than size influence transport and that the impact is greater at shorter lengths. Differential penetration between equal sized oligonucleotides synthesized with identical bases in reversed order indicates that sequence and not simply base composition affects steady-state flux across skin. Molecular structure, therefore, is a key contributor to iontophoretically assisted transport. Further studies are necessary to develop more precise predictions about the relationship between oligonucleotide structure and transdermal delivery.

UR - http://www.scopus.com/inward/record.url?scp=0031889133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031889133&partnerID=8YFLogxK

U2 - 10.1021/js9701871

DO - 10.1021/js9701871

M3 - Article

VL - 87

SP - 49

EP - 52

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 1

ER -